| Literature DB >> 34139039 |
Eriola Hoxha1,2, Ilaria Balbo1,2, Roberta Parolisi1, Matteo Audano3, Francesca Montarolo1, Francesco Ravera1, Michela Guglielmotto1,2, Luisa Muratori1,4, Stefania Raimondo1,4, Eleonora DiGregorio5, Annalisa Buffo1,2, Alfredo Brusco5, Barbara Borroni6, Nico Mitro3, Donatella Caruso3, Filippo Tempia1,2,7.
Abstract
Elovl5 elongates fatty acids with 18 carbon atoms and in cooperation with other enzymes guarantees the normal levels of very long-chain fatty acids, which are necessary for a proper membrane structure. Action potential conduction along myelinated axons depends on structural integrity of myelin, which is maintained by a correct amount of fatty acids and a proper interaction between fatty acids and myelin proteins. We hypothesized that in Elovl5-/- mice, the lack of elongation of Elovl5 substrates might cause alterations of myelin structure. The analysis of myelin ultrastructure showed an enlarged periodicity with reduced G-ratio across all axonal diameters. We hypothesized that the structural alteration of myelin might affect the conduction of action potentials. The sciatic nerve conduction velocity was significantly reduced without change in the amplitude of the nerve compound potential, suggesting a myelin defect without a concomitant axonal degeneration. Since Elovl5 is important in attaining normal amounts of polyunsaturated fatty acids, which are the principal component of myelin, we performed a lipidomic analysis of peripheral nerves of Elovl5-deficient mice. The results revealed an unbalance, with reduction of fatty acids longer than 18 carbon atoms relative to shorter ones. In addition, the ratio of saturated to unsaturated fatty acids was strongly increased. These findings point out the essential role of Elovl5 in the peripheral nervous system in supporting the normal structure of myelin, which is the key element for a proper conduction of electrical signals along myelinated nerves.Entities:
Keywords: Elovl5; action potential; axon; myelin; polyunsaturated fatty acids
Mesh:
Substances:
Year: 2021 PMID: 34139039 PMCID: PMC8453547 DOI: 10.1002/glia.24048
Source DB: PubMed Journal: Glia ISSN: 0894-1491 Impact factor: 7.452
FIGURE 1Structural alterations of sciatic nerve of Elovl5 −/− mice. (a) Representative images of fibers in wild type and in Elov5 sciatic nerves (scale Bar = 10 μm). (b) Ultra structural representation of myelin periodicity (scale Bar = 40 nm) and of the distance between consecutive major dense lines (Elov5 n = 3 mice vs. wild type n = 3 mice). (c) bar graph representing the G‐ratio (inner perimeter/outer perimeter) of sciatic nerve myelinated fibers (Elov5 n = 4 mice vs. wild type n = 3 mice). (d) Graph representing the relative frequency of axonal diameters (μm) (Elov5 n = 4 vs. wild type n = 3). (e) Bar graph representing myelin sheath thickness (mm) of sciatic nerve myelinated fibers (Elov5 n = 5 vs wild type n = 4). (f) G‐ratio quantification of fibers accounting for axon diameter (Elov5 n = 4 vs. wild type n = 3). Data are expressed as mean ± SEM and p‐values are determined by the appropriate statistical test. *p < .05; ***p < .001
FIGURE 2Increased length of the node/paranode complexes of sciatic nerves of Elovl5 −/− mice. Confocal images of a single teased sciatic nerve from (a) wild type (n = 3) and (b) Elovl5 −/− mice (n = 3) showing paranodes labeled for Caspr (red). (c) Histogram distribution of nodal gap length (p < .001, Kolmogorov–Smirnov test) and (d) mean ± SEM of the node lengths for wild type (blue) and Elovl5 −/− mice (red) (Student's t‐test, p < .05). (e) Histogram distribution of paranodal length (p < .001, Kolmogorov–Smirnov test) and (f) mean ± SEM of paranodal length (Student's t‐test, p < .05). (g) Histogram distribution of node/paranode length (p < .001, Kolmogorov–Smirnov test) and (h) mean ± SEM of node/paranode length (Student's t‐test, p < .05). *p < .05; ***p < .001
FIGURE 3Reduced action potential propagation in peripheral axons of Elovl5 mice. (a) Representative traces of action potentials evoked by stimulation of the tail nerve for wild type (black) and Elovl5 mice (light gray). (b–e) Bar graphs representing mean values of latency, nerve conduction velocity, action potential duration and action potential area respectively (Elov5 n = 5 mice vs. wild type n = 4 mice). Data are expressed as mean ± SEM and p‐values are determined by unpaired Student's t‐test. *p < .05; ***p < .001
FIGURE 4Proteins of myelin. (a) Representative western blots of sciatic nerve extracts from wild type and Elov5 mice. (b) Densitometric quantification shows comparable levels of MBP, MPZ, and CNPase proteins in the sciatic nerve extracts of Elov5 mice compared to their control littermates (wild type n = 5; Elov5 n = 6). β Actin served as loading control
FIGURE 5Altered phospholipid profile of Elovl5 sciatic nerve. Fold change of the main classes of phospholipids in Elov5 sciatic nerve relative to wild type. The fold change is represented by the size of the circles (see scale legend on the right). The color (from gray to red) represents the statistical significance level (1/p) with full red corresponding to p ≤ .001 (see color legend on the right). Note that the significant increases concern phospholipids with 2 acyl chains with 3 or <3 unsaturated bonds and with up to 36 carbon atoms. The significantly decreased phospholipids with 2 acyl chains have >3 unsaturated bonds and >36 carbon atoms. PCaa, phosphatidylcholines; PCae, plasmenylcholines; PEaa, phosphatidylethanolamines; PEae, plasmenylethalomines; PS, phosphatidylserines; PG, phosphatidylglycerols; PI, phosphatidylinositols; PA, phosphatidic acids; LPA, lysophosphatidic acids; lyso PC, lysophosphatidylcholines; lyso PE, lysophosphatidylethanolamines; SM, sphingomyelins and sphingomyelins(OH) (the latter are plotted slightly upward shifted); Cer, ceramides; LacCer, lactosylceramides; GCer, glucosylceramides; Sul, sulfatides